STOCK TITAN

Iiot-Oxys Inc SEC Filings

ITOX OTC Link

Welcome to our dedicated page for Iiot-Oxys SEC filings (Ticker: ITOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

IIOT-OXYS, Inc. filings document the reporting obligations, capital structure, and material events of a Nevada technology company quoted under ITOX. The filing record includes Forms 8-K for securities purchase agreements, amendments to preferred-stock designations, promissory note extensions, and debt-exchange matters.

Company disclosures also cover Series D Convertible Preferred Stock, Series A Super-voting Preferred Stock, relationships with financing counterparties, and notifications of late Form 10-K or Form 10-Q filings tied to the completion of auditor review processes. These records provide formal detail on governance actions, financing instruments, and periodic-reporting status.

Rhea-AI Summary

IIOT-OXYS, Inc. reported no revenue for the three months ended March 31, 2026 and a net loss attributable to common stockholders of $393,673, up from $180,313 a year earlier, driven mainly by operating expenses and sizable preferred stock dividends of $167,511.

Cash and cash equivalents fell to $6,838 from $26,342 at December 31, 2025, with operating activities using $59,624 of cash. The company had a working capital deficit of $2,653,885, total stockholders’ deficit of $3,726,485, and an accumulated deficit of $13,043,185.

Management states these conditions, along with reliance on external financing, raise substantial doubt about the company’s ability to continue as a going concern. Liquidity has been supported by issuing Series B, C and D convertible preferred stock to GHS Investments, which also created significant derivative liabilities and cumulative preferred dividends, some of which GHS has contractually waived.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

IIOT-OXYS, Inc. amended its March 6, 2026 Securities Purchase Agreement with GHS Investments, LLC to allow two additional closings of Series D Convertible Preferred Stock. The amendment increases the total Series D shares authorized under the agreement to 167.

GHS may purchase up to 37 Series D shares in a Second Additional Closing and up to 27 shares in a Third Additional Closing, each with 3 extra shares as an equity incentive. On June 16, 2026, the company completed the Third Additional Closing, issuing 30 Series D shares to GHS for $27,000 plus 3 incentive shares, in a private offering relying on Section 4(a)(2) and Rule 506(b).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

IIOT-OXYS, Inc. has amended a small piece of its debt. The company and GHS Investments LLC agreed to Extension No. 7 of a $75,000 Convertible Promissory Note originally issued on July 29, 2020, moving the note’s maturity date to October 31, 2026.

The note had already been extended several times, most recently to April 29, 2026. As part of the new extension, GHS waived all prior Events of Default, whether known or unknown, as of the extension’s effective date, reducing near-term repayment pressure and clearing past default issues on this instrument.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

IIOT-OXYS, Inc. submitted a Form 12b-25 notifying the SEC that its quarterly report on Form 10-Q for the period ended March 31, 2026 will be late. The company states the delay is because it has been unable to complete the review process with the auditor. The notice is signed by Clifford L. Emmons, Chief Executive Officer and dated May 15, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

IIOT-OXYS, Inc. reports full-year 2025 results with no revenue, compared with $2,500 in 2024, and a larger net loss attributable to common stockholders of $1,441,260 versus $764,655 a year earlier.

Operating expenses rose to $532,791, driven by higher amortization of intangible assets and legal and professional fees. Preferred stock dividends increased sharply to $783,414, adding to losses for common shareholders. Cash at year-end was $26,342, and the company disclosed a working capital deficit of $2,309,032 and an accumulated deficit of $12,649,512, leading to substantial doubt about its ability to continue as a going concern.

The company raised $210,000 through sales of Series D Convertible Preferred Stock and executed several debt-for-equity exchanges, while control shifted on November 5, 2025 to GHS Investments, LLC via issuance of Series A Supervoting Preferred Stock. As of May 11, 2026, there were 586,385,063 common shares outstanding and the stock traded at sub-penny levels on the OTC market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

IIOT-OXYS, Inc. amended the terms of its Series D Convertible Preferred Stock. The company’s board and the sole holder approved an amendment to the Certificate of Designation that increases the number of designated Series D Preferred shares from 210 to up to 500.

Each Series D share continues to have a par value of $0.001 and a stated value of $1,200, with potential increases as described in the amended Certificate of Designation. Any further increase in the number of Series D shares requires the written consent of all holders of this preferred series.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

IIOT-OXYS, Inc. reported a restructuring transaction involving its former director, Vidhyadhar Mitta. Under a Debt Exchange Agreement, Mr. Mitta exchanged $216,156 of principal and accrued interest from a 12% secured convertible note for 180 shares of Series E Convertible Preferred Stock, and agreed to cancel 12,000 shares of Series A Super-Voting Preferred Stock.

Each Series A share may be converted into common stock at a 1:100 rate, and each Series E share is convertible into common stock at $0.0005 per share. The filing shows 1,200,000 common shares underlying the cancelled Series A and 432,000,000 common shares underlying the newly issued Series E. Separately, Mr. Mitta directly and beneficially owns 1,736,843 shares of common stock, which are not part of these derivative conversions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

IIOT-OXYS, Inc. CEO Clifford L. Emmons restructured his holdings through a debt-for-equity exchange involving preferred stock. He exchanged $387,242 of accrued and unpaid fees owed by the company for 268.529 shares of Series E Convertible Preferred Stock and agreed to cancel 7,800 shares of Series A Supervoting Preferred Stock he owned. Each Series A share may be converted into common stock at a 1:100 rate, while the Series E shares are convertible into common stock at $0.0005 per share and are subject to a 4.99% beneficial ownership limitation. Following these changes, Emmons is reported as directly and beneficially owning 9,280,000 shares of common stock, separate from any common shares issuable from derivative securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

IIOT-OXYS, Inc. former CFO Karen McNemar restructured her preferred stock and debt position through non-market transactions. She canceled 6,045 shares of Series A Super-Voting Preferred Stock and exchanged $323,269 of accrued and unpaid fees for 269 shares of Series E Convertible Preferred Stock.

Each Series A share is voluntarily convertible into common stock at a 1:100 ratio, while each Series E share is convertible at $0.0005 per common share and is subject to a 4.99% beneficial ownership limitation. After these changes, she directly and beneficially owns 8,804,500 common shares, excluding any common shares issuable from the preferred stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

IIOT-OXYS, Inc. filed a Form 12b-25 notifying the SEC that its Annual Report on Form 10-K for the period ended December 31, 2025 will be late. The company states the delay is because it "has been unable to complete the review process with the auditor." The notification is signed by Clifford L. Emmons, Chief Executive Officer on March 31, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Iiot-Oxys (ITOX) SEC filings are available on StockTitan?

StockTitan tracks 20 SEC filings for Iiot-Oxys (ITOX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Iiot-Oxys (ITOX)?

The most recent SEC filing for Iiot-Oxys (ITOX) was filed on July 9, 2026.